Related Experiment Video
Updated: Sep 12, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
Longitudinal structural MRI-based deep learning and radiomics features for predicting Alzheimer's disease progression
Sepehr Aghajanian1,2, Fateme Mohammadifard3, Ida Mohammadi4
1Department of Neurosurgery, Alborz University of Medical Sciences, Karaj, Iran. Sepehraghajanian2@gmail.com.
Alzheimer'S Research & Therapy
|August 7, 2025
Summary
Early Alzheimer's disease (AD) detection is crucial. Deep learning models using longitudinal MRI scans accurately predict mild cognitive impairment (MCI) to AD conversion, enabling timely interventions.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Gerontology
Background:
- Alzheimer's disease (AD) is the leading cause of dementia.
- Early diagnosis of mild cognitive impairment (MCI) is vital for managing progression and treatment.
- Structural MRI and deep learning (DL) show promise for detecting neurodegeneration.
Purpose of the Study:
- To evaluate the efficacy of DL models in predicting MCI to AD conversion using longitudinal MRI data.
- To identify key MRI-based biomarkers for early AD detection.
Main Methods:
- Utilized T1-weighted MRI scans from 228 MCI participants in the ADNI database.
- Employed a 3D Residual Network (ResNet3D) for single-timepoint analysis and a Long Short-Term Memory (LSTM) model with attention for longitudinal analysis.
- Extracted radiomics features from gray matter segmentation.
Main Results:
- A single-timepoint DL model achieved a c-index of ~0.70.
- Longitudinal analysis significantly improved prediction accuracy (c-index: 0.80-0.90) with high AUC (>0.85) for 2-5 year prediction windows.
- Gray matter surface-to-volume ratio and elongation were identified as key predictive radiomics features.
Conclusions:
- Advanced DL architectures combined with structural MRI are valuable for predicting MCI to AD conversion.
- This approach facilitates early risk stratification and personalized interventions for individuals at high risk of AD progression.
- Future research requires larger, diverse cohorts to validate findings and explore further enhancements.

